Your session is about to expire
β Back to Search
Facebook Group for Tobacco Smoking (CAN Quit Trial)
N/A
Waitlist Available
Led By Christi A Patten, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Inclusion
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Summary
This trial tests a Facebook-based program designed to help Alaska Native smokers quit by sharing relatable stories and tips. The goal is to provide a culturally relevant way to support smoking cessation in this high-risk group. The CAN Quit program is a Facebook-based intervention developed to promote smoking cessation among Alaska Native people by connecting them with culturally relevant resources and support.
Eligible Conditions
- Tobacco Smoking
- Smoking
- Smoking Cessation
- Tobacco Use
- Smoking/Cigarette Smoking
- Quitting Smoking
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Biochemically Confirmed Abstinence From Smoking
Smoking Cessation Program Completion
Secondary outcome measures
Quit Attempts
Self-reported 7-day Point Prevalence Smoking Abstinence
Self-reported Use of Evidence-based Cessation Treatments
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Facebook+Quitline/Treatment ReferralExperimental Treatment1 Intervention
Participants join a secret/private, culturally relevant Facebook group moderated by an AN tobacco research counselor for 3 months
Once daily moderator postings for 30 days, repeated each month for 3 months; plus 3-4 daily check-ins/postings to respond to participant generated content and encourage sharing of personal stories/experiences relevant to all stages of the quitting process and treatment engagement
Description of tobacco treatment services, phone numbers and web links sent via postal mail (printed materials) and email. Treatment options provide free, professional assistance based on U.S. clinical practice guidelines: (1)AK quitline, (2)regional tribal tobacco cessation programs, and (3)smokefree.gov resources (e.g., free texting program and smartphone application, quit guide)
Group II: Quitline/Treatment ReferralActive Control1 Intervention
Description of tobacco treatment services, phone numbers and web links sent via postal mail (printed materials) and email. Treatment options provide free, professional assistance based on U.S. clinical practice guidelines: (1)AK quitline, (2)regional tribal tobacco cessation programs, and (3)smokefree.gov resources (e.g., free texting program and smartphone application, quit guide)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Facebook Group
2019
N/A
~190
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,345 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,503 Previous Clinical Trials
2,625,522 Total Patients Enrolled
Christi A Patten, Ph.D.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
70 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger